Quantbot Technologies LP Cuts Holdings in Axcelis Technologies, Inc. $ACLS

Quantbot Technologies LP lowered its position in Axcelis Technologies, Inc. (NASDAQ:ACLS) by 54.2% during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 16,156 shares of the semiconductor company’s stock after selling 19,122 shares during the quarter. Quantbot Technologies LP owned 0.05% of Axcelis Technologies worth $1,577,000 as of its most recent filing with the Securities and Exchange Commission.

Several other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Salomon & Ludwin LLC acquired a new position in shares of Axcelis Technologies in the 3rd quarter valued at about $25,000. Close Asset Management Ltd purchased a new position in Axcelis Technologies in the third quarter valued at approximately $27,000. EverSource Wealth Advisors LLC lifted its position in Axcelis Technologies by 145.1% during the second quarter. EverSource Wealth Advisors LLC now owns 451 shares of the semiconductor company’s stock valued at $31,000 after buying an additional 267 shares in the last quarter. Caitlin John LLC purchased a new stake in Axcelis Technologies during the third quarter worth approximately $32,000. Finally, Strs Ohio acquired a new stake in shares of Axcelis Technologies in the third quarter worth $49,000. 89.98% of the stock is currently owned by institutional investors and hedge funds.

Axcelis Technologies Stock Down 0.8%

Shares of NASDAQ ACLS opened at $85.91 on Friday. Axcelis Technologies, Inc. has a 1 year low of $40.40 and a 1 year high of $102.93. The firm has a market cap of $2.64 billion, a price-to-earnings ratio of 22.67, a PEG ratio of 10.35 and a beta of 1.78. The company has a debt-to-equity ratio of 0.04, a quick ratio of 3.11 and a current ratio of 4.77. The stock’s 50-day simple moving average is $88.05 and its 200-day simple moving average is $85.88.

Axcelis Technologies (NASDAQ:ACLS) last issued its quarterly earnings results on Tuesday, February 17th. The semiconductor company reported $1.49 EPS for the quarter, beating analysts’ consensus estimates of $1.12 by $0.37. Axcelis Technologies had a return on equity of 13.73% and a net margin of 14.33%.The firm had revenue of $238.33 million during the quarter, compared to the consensus estimate of $215.04 million. During the same quarter in the prior year, the business posted $1.54 earnings per share. Axcelis Technologies’s revenue for the quarter was down 5.6% on a year-over-year basis. Axcelis Technologies has set its Q1 2026 guidance at 0.710-0.710 EPS. As a group, equities analysts anticipate that Axcelis Technologies, Inc. will post 2.55 earnings per share for the current fiscal year.

Analyst Ratings Changes

Several research firms recently weighed in on ACLS. Bank of America lifted their target price on shares of Axcelis Technologies from $90.00 to $100.00 and gave the company an “underperform” rating in a report on Tuesday, January 13th. B. Riley Financial reduced their price objective on Axcelis Technologies from $94.00 to $91.00 and set a “neutral” rating on the stock in a research note on Wednesday, February 18th. Zacks Research lowered Axcelis Technologies from a “hold” rating to a “strong sell” rating in a research note on Friday, February 20th. Wall Street Zen downgraded Axcelis Technologies from a “buy” rating to a “hold” rating in a report on Saturday, January 3rd. Finally, Weiss Ratings restated a “hold (c-)” rating on shares of Axcelis Technologies in a report on Monday, December 22nd. Two equities research analysts have rated the stock with a Buy rating, two have issued a Hold rating and two have issued a Sell rating to the stock. Based on data from MarketBeat, the stock presently has an average rating of “Hold” and an average target price of $101.50.

Insiders Place Their Bets

In other Axcelis Technologies news, Director Jorge Titinger sold 1,000 shares of the firm’s stock in a transaction on Friday, February 20th. The shares were sold at an average price of $80.00, for a total transaction of $80,000.00. Following the completion of the transaction, the director directly owned 6,477 shares of the company’s stock, valued at $518,160. This trade represents a 13.37% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, EVP Gerald M. Blumenstock sold 3,034 shares of the business’s stock in a transaction dated Thursday, December 11th. The stock was sold at an average price of $89.46, for a total transaction of $271,421.64. Following the completion of the sale, the executive vice president directly owned 18,661 shares of the company’s stock, valued at $1,669,413.06. The trade was a 13.98% decrease in their position. The SEC filing for this sale provides additional information. In the last 90 days, insiders sold 6,034 shares of company stock valued at $523,522. Insiders own 0.48% of the company’s stock.

Axcelis Technologies Profile

Axcelis Technologies, Inc is a leading developer and manufacturer of ion implantation and cleaning equipment used in the fabrication of semiconductor chips. The company specializes in high-current, medium-current and high-energy ion implantation systems, which are critical for introducing precisely controlled dopants into silicon wafers. Axcelis also offers plasma-based cleaning and dry strip tools that support advanced process nodes in logic, memory and power device manufacturing.

The company’s product portfolio encompasses single-wafer and multi-wafer cluster tools designed to deliver high throughput, accuracy and uniformity for semiconductor process steps.